BiotechTube
Home/Pipeline/Cryptic Target™ Therapeutics

Cryptic Target™ Therapeutics

Oncology (unspecified)

PreclinicalActive

Key Facts

Indication
Oncology (unspecified)
Phase
Preclinical
Status
Active
Company
RyboDyn

About RyboDyn

RyboDyn is a private, preclinical-stage biotech founded in 2018 and based in San Diego, CA. The company is focused on decoding the dark proteome to discover novel immunotherapy targets that are invisible to conventional genomics and proteomics methods. Its core asset is the RyboCypher™ platform, an AI-driven engine that has already identified thousands of novel cancer-associated peptides. RyboDyn is leveraging this platform to build a pipeline of antibody therapeutics aimed at high-specificity treatments for cancer and other diseases.

View full company profile

Therapeutic Areas

Oncology

Other Oncology (unspecified) Drugs

DrugCompanyPhase
Oncology Vaccine ProgramCHAIN BiotechPre-clinical
ARX305NovoCodex BiopharmaceuticalsPhase 1
ARX788NovoCodex BiopharmaceuticalsPhase 1
Cancer Immunotherapy NanotherapeuticFlashpoint TherapeuticsPhase 1
GRWD5769Greywolf TherapeuticsPhase 1/2
Platform-derived Program(s)Immuto ScientificDiscovery/Pre-clinical
MBT Oncology ProgramIonic PharmaceuticalsPre-clinical
ISB 2301Ichnos Glenmark InnovationPreclinical
GRC 65327Ichnos Glenmark InnovationPreclinical
Platform-Derived PipelinePhinomicsDiscovery/Pre-clinical
Lead Small-Molecule InhibitorEris BiotechPre-clinical
Orotecan™Edison OncologyPhase 1/2a